Copyright
|
Site Map
|
About Us
Products
Research
Clinical
News
Contact
Home
Clinical Development
»
Clinical Data & Updates
Clinical Data and Updates
2008-06-02
Data Presented at ASCO: Apthera’s NeuVax™ Produces Delays in Recurrence in High-Risk HER2-Positive Prostate Cancer Patients
2008-04-14
Recurrence Data Presented at AACR: Low HER2 Expressing Breast Cancer Patients Respond Preferentially to Apthera’s NeuVax™
2007-08-29
End-of-Phase II Meeting with U.S. FDA for NeuVax
2006-12-14
NeuVax Phase I/II Results in Breast Cancer
